SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

GlaxoSmithkline Consumer Healthcare informs about Board meeting

22 Oct 2014 Evaluate

GlaxoSmithkline Consumer Healthcare has informed that a meeting of the Board of Directors of the Company will be held on November 05, 2014, to consider and take on record the Un-audited Financial Results for the quarter ended September 30, 2014 (Q2) with Limited Review done by the Statutory Auditors.

The above information is a part of company’s filings submitted to BSE.

Glaxo.Cons. Health Share Price

9696.40 0.00 (0.00%)
15-Apr-2020 18:01 View Price Chart
Peers
Company Name CMP
Varun Beverages 452.00
Nestle 1250.00
Britannia Inds 5564.85
LT Foods 414.40
Hatsun Agro Product 939.40
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×